A systematic review on the possible role of microRNA-155 in cancer treatment

Shruthi Nagainallur Ravichandran, Antara Banerjee, Pier Paolo Parnigotto, Surajit Pathak, Silvia Barbon

Open source

DOI
10.3389/fphar.2026.1885427
Published
2026-10-20
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1885427,
  title = {A systematic review on the possible role of microRNA-155 in cancer treatment},
  author = {Shruthi Nagainallur Ravichandran and Antara Banerjee and Pier Paolo Parnigotto and Surajit Pathak and Silvia Barbon},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1885427},
  url = {https://doi.org/10.3389/fphar.2026.1885427}
}

RIS

TY  - JOUR
TI  - A systematic review on the possible role of microRNA-155 in cancer treatment
AU  - Shruthi Nagainallur Ravichandran
AU  - Antara Banerjee
AU  - Pier Paolo Parnigotto
AU  - Surajit Pathak
AU  - Silvia Barbon
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1885427
UR  - https://doi.org/10.3389/fphar.2026.1885427
ER  - 

APA

Ravichandran, S. N., Banerjee, A., Parnigotto, P. P., Pathak, S., & Barbon, S. (2026). A systematic review on the possible role of microRNA-155 in cancer treatment. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1885427

Source records